Brief: AroCell: FDA Resumes Review Of AroCells 510(k) Submission

IDL Diagnostics AB (publ)

16/04/2021 07:34

April 16 (Reuters) - AroCell AB (publ)  AROC.ST :
    * FDA RESUMES REVIEW OF AROCELLS 510(K)SUBMISSION
    * US FOOD AND DRUG ADMINISTRATION (FDA) HAS RESUMES AROCELLS
510(K) SUBMISSION AFTER IMPACT OF RELOCATION DUE TO COVID-19
PANDEMIC.

Source text for Eikon:  ID:nMFNb4g7XG 
Further company coverage:  AROC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))